Literature DB >> 2420770

Radiation therapy of giant cell tumor of bone: analysis of 35 patients.

Z X Chen, D Z Gu, Z H Yu, T N Qian, Y R Huang, Y H Hu, X Z Gu.   

Abstract

This paper reports 35 patients treated for giant cell tumor of bone. Ten patients were treated by surgery followed by postoperative irradiation. All 10 were cured; eight have survived for more than 5 years and four for more than 10 years without recurrence. Twenty-five patients were treated by radiation alone. All patients were followed for 2 to 17 years. For those who received more than 3500 rad, the local control rate was 82% (14/17); for those who received more than 4000 rad, the local control rate was 85% (11/13). Thirteen have lived for more than 5 years and nine have lived for more than 10. Our experience reveals that surgery and postoperative radiation produce the best results, and that these results are better than those reported in the literature. The results of radiation alone are comparable to that of surgery. For lesions not amenable to surgery, or those which would become crippling if surgery is attempted, radiation should be used either alone or in combination with conservative surgery. The dose for radiation alone should be 5000 to 6000 rad and for postoperative radiation, 3000 to 4000 rad. Supervoltage X rays (60Co or 8 Mv X ray), but not orthovoltage X rays, are indicated. A single radiation course with higher dose is preferred to multiple courses with lower doses. In 62% (15/24) of patients, pain relief begins before treatment is completed. In 74% (14/19) of patients, the tumor mass will not resolve until the sixth month after radiation.

Entities:  

Mesh:

Year:  1986        PMID: 2420770     DOI: 10.1016/0360-3016(86)90346-9

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  6 in total

1.  Treatment options and prognosis for repeatedly recurrent giant cell tumor of the spine.

Authors:  Yifei Ma; Jialin Li; Jun Pan; Wangjun Yan; Quan Huang; Tielong Liu; Xinghai Yang; Cheng Yang; Wei Xu; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2016-03-17       Impact factor: 3.134

Review 2.  Therapeutic radiotherapy for giant cell tumor of the spine: a systemic review.

Authors:  Yifei Ma; Wei Xu; Huabin Yin; Quan Huang; Tielong Liu; Xinghai Yang; Haifeng Wei; Jianru Xiao
Journal:  Eur Spine J       Date:  2015-05-06       Impact factor: 3.134

Review 3.  Intensity modulated radiotherapy (IMRT) in benign giant cell tumors--a single institution case series and a short review of the literature.

Authors:  Falk Roeder; Carmen Timke; Felix Zwicker; Christian Thieke; Marc Bischof; Jürgen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2010-02-26       Impact factor: 3.481

4.  Giant cell tumor of temporomandibular joint masquerading as temporomandibular joint pain dysfunction syndrome: a rare case report.

Authors:  Jo Ee Sam; Rullyandrianto Pan Nuriman Rachmat; Cri Saiful Jordan Melano; Nasser Abdul Wahab
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-04-25

5.  Rank ligand as a target in musculoskeletal neoplasms.

Authors:  Gregory M Cote
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

6.  Treatment for giant cell tumor of the spine metastasizing to the lung: A report of two cases and a literature review.

Authors:  Aikeremujiang Muheremu; Zhen Huang; Xiaohui Niu
Journal:  Oncol Lett       Date:  2014-12-30       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.